Stelios Papadopoulos Biogen Inc. (BIIB) insider trading activity

Stelios Papadopoulos is Director of BIOGEN INC.. Currently has a direct ownership of 10,095 shares of BIIB, which is worth approximately $1.75 Million. The most recent transaction as insider was on Jun 15, 2022, when has been sold 2,255 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.1K

0% 3M change

0% 12M change

Total Value Held $1.75 Million

STELIOS PAPADOPOULOS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 15 2022	BUY Grant, award, or other acquisition	-	2,255 Added 18.26%	10,095 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	1,275 Added 13.99%	7,840 Common Stock

Also insider at

EUCRW

Eucrates Biomedical Acquisition Corp.

Director

RGLS

Regulus Therapeutics Inc. Healthcare

EXEL

EXELIXIS, INC. Healthcare

Director